These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 20201753)

  • 1. Effects of different dose of FTY720 on lymphocyte cell cycle arrest in cardiac transplantation model of rats.
    Li Q; Li F
    Immunopharmacol Immunotoxicol; 2010 Dec; 32(4):680-7. PubMed ID: 20201753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rejection following donor or recipient preoperative treatment with FTY720 in rat small bowel transplantation.
    Sakagawa T; Kiyochi H; Honda K; Kobayashi N
    Transpl Immunol; 2004 Nov; 13(3):161-8. PubMed ID: 15381198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell cycle arrest effects of large-dose FTY720 on lymphocytes in mouse skin transplantation models.
    Li QY; Chi YY; Liu SQ
    Immunopharmacol Immunotoxicol; 2008; 30(2):365-81. PubMed ID: 18569090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient T cell accumulation in lymph nodes and sustained lymphopenia in mice treated with FTY720.
    Morris MA; Gibb DR; Picard F; Brinkmann V; Straume M; Ley K
    Eur J Immunol; 2005 Dec; 35(12):3570-80. PubMed ID: 16285007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effect of FTY720 on lymphocyte count and islet allograft survival in mice.
    Liu L; Wang C; He X; Shang W; Bi Y; Wang D
    Microsurgery; 2007; 27(4):300-4. PubMed ID: 17477424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing.
    Chiba K; Yanagawa Y; Masubuchi Y; Kataoka H; Kawaguchi T; Ohtsuki M; Hoshino Y
    J Immunol; 1998 May; 160(10):5037-44. PubMed ID: 9590253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunosuppressive effect of S1P1 receptor agonist FTY720].
    Zhou WQ; Zhang HJ; Jin J; Li Y; Li C; Chen XG
    Yao Xue Xue Bao; 2012 Apr; 47(4):546-50. PubMed ID: 22799042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FTY720, a new immunosuppressant, as rescue therapy in mouse cardiac transplantation.
    Wang MH; Milekhin V; Zhang H; Huang HZ
    Acta Pharmacol Sin; 2003 Sep; 24(9):847-52. PubMed ID: 12956930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors.
    Chiba K
    Pharmacol Ther; 2005 Dec; 108(3):308-19. PubMed ID: 15951022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of FTY720 on rat lymphoid organs.
    Takai K; Takahara S; Isoyama N; Tsuchida M; Matsumura M; Kishi Y; Uchiyama K; Naito K
    Transplant Proc; 2004 Oct; 36(8):2453-6. PubMed ID: 15561279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FTY720 in combination with cyclosporine--an analysis of skin allograft survival and renal function.
    Silva FR; Silva LB; Cury PM; Burdmann EA; Bueno V
    Int Immunopharmacol; 2006 Dec; 6(13-14):1911-8. PubMed ID: 17161344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FTY720 reduces extracellular matrix expansion associated with ischemia-reperfusion induced injury.
    Delbridge MS; Shrestha BM; Raftery AT; El Nahas AM; Haylor J
    Transplant Proc; 2007 Dec; 39(10):2992-6. PubMed ID: 18089307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of FTY720 on M1 and M2 macrophages, lymphocytes, and chemokines in 5/6 nephrectomized rats.
    Schaier M; Vorwalder S; Sommerer C; Dikow R; Hug F; Gross ML; Waldherr R; Zeier M
    Am J Physiol Renal Physiol; 2009 Sep; 297(3):F769-80. PubMed ID: 19535570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [FTY720-induced lymphocyte apoptosis inhibits acute graft versus host disease in rat small bowel transplantation].
    Song JH; Ito T; Wei JM; Huang MX
    Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Jan; 13(1):60-3. PubMed ID: 20099165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo.
    Yanagawa Y; Sugahara K; Kataoka H; Kawaguchi T; Masubuchi Y; Chiba K
    J Immunol; 1998 Jun; 160(11):5493-9. PubMed ID: 9605152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FTY720 reduces T-cell recruitment into murine intestinal allograft and prevents activation of graft-infiltrating cells.
    Kimura T; Hasegawa T; Nakai H; Azuma T; Usui N; Sasaki T; Okada A
    Transplantation; 2003 May; 75(9):1469-74. PubMed ID: 12792499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lymphocyte migration inhibitor FTY720 attenuates experimental hypertensive nephropathy.
    Krämer S; Binder E; Loof T; Wang-Rosenke Y; Martini S; Khadzhynov D; Budde K; Neumayer HH; Peters H
    Am J Physiol Renal Physiol; 2009 Jul; 297(1):F218-27. PubMed ID: 19439518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of a novel immunosuppressant, FTY720, in mice without secondary lymphoid organs.
    Sugito K; Koshinaga T; Inoue M; Ikeda T; Hagiwara N; Fukuzawa M
    Surg Today; 2005; 35(8):662-7. PubMed ID: 16034547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FTY720, an immunosuppressant that alters lymphocyte trafficking, abrogates chronic rejection in combination with cyclosporine A.
    Koshiba T; Van Damme B; Rutgeerts O; Waer M; Pirenne J
    Transplantation; 2003 Apr; 75(7):945-52. PubMed ID: 12698078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Nofer JR; Bot M; Brodde M; Taylor PJ; Salm P; Brinkmann V; van Berkel T; Assmann G; Biessen EA
    Circulation; 2007 Jan; 115(4):501-8. PubMed ID: 17242282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.